⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL702983 | 0.98 | — | — | |
| SCHEMBL28014139 | 0.81 | — | — | |
| SCHEMBL15382664 | 0.81 | — | — | |
| SCHEMBL391332 | 0.79 | GAA (0.65) | — | |
| SCHEMBL23561304 | 0.79 | GAA (0.65) | — | |
| Benzylhydrazine SCHEMBL7876917 | 0.79 | PPID (0.64) | — | |
| SCHEMBL1515500 | 0.78 | ALDH1A1 (0.50) | — | |
| SCHEMBL3042437 | 0.78 | GAA (0.53) | — | |
| SCHEMBL179686 | 0.77 | — | — | |
| SCHEMBL4394629 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954778-A | Synthesis method of lenacipam sodium and series of intermediate compounds thereof | 杭州科巢生物科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-114478410-B | Disubstituted phenyl-1, 2, 4-triazole derivative, and preparation and application thereof | 中山大学 | 2022-11-29 | — | — | CN | claimed |
| CN-114591254-A | 3, 5-disubstituted phenyl-1, 2, 4-triazole derivative and preparation method and application thereof | 中山大学 | 2022-06-07 | — | — | CN | claimed |
| CN-114478410-A | Disubstituted phenyl-1, 2, 4-triazole derivative and preparation and application thereof | 中山大学 | 2022-05-13 | — | — | CN | claimed |
| CN-110845356-B | Synthesis method of hydrazino ethyl acetate hydrochloride | 苏州永健生物医药有限公司 | 2022-03-04 | — | — | CN | claimed |
| US-11241455-B2 | Methods of treating disease by metabolic control of T-cell differentiation | THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE (US) | 2022-02-08 | — | — | US | claimed |
| CN-110845356-A | Synthesis method of hydrazino ethyl acetate hydrochloride | 苏州永健生物医药有限公司 | 2020-02-28 | — | — | CN | claimed |
| US-20190022142-A1 | METHODS OF TREATING DISEASE BY METABOLIC CONTROL OF T-CELL DIFFERENTIATION | THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE | 2019-01-24 | — | — | US | claimed |
| EP-3402571-A1 | METHODS OF TREATING DISEASE BY METABOLIC CONTROL OF T-CELL DIFFERENTIATION | The J. David Gladstone Institutes (US) | 2018-11-21 | — | — | EP | claimed |
| WO-2017123808-A1 | METHODS OF TREATING DISEASE BY METABOLIC CONTROL OF T-CELL DIFFERENTIATION | THE J. DAVID GLADSTONE INSTITUTES (US) | 2017-07-20 | — | — | WO | claimed |
| CN-103209982-A | Novel compound of a reverse-turn mimetic and a production method and use therefor | JW PHARMACEUTICAL CORP | 2013-07-17 | — | — | CN | claimed |
| EP-1636219-B1 | NOVEL THIAZOLYLMETHYL PYRAZOLES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF IN DYES FOR KERATIN FIBERS | WELLA AG (DE) | 2006-11-02 | — | — | EP | claimed |
| US-20060183781-A1 | Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers | WELLA AG (DE) | 2006-08-17 | — | — | US | claimed |
| US-4101658-A | Antibacterial hydrazono cephalosporins | SHIONOGI & CO., LTD. (JP) | 1978-07-18 | — | — | US | claimed |
| US-20260102383-A1 | LPAR1 Inhibitors | ABBVIE INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4711368-A1 | AZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2026-03-18 | — | — | EP | disclosed |
| EP-4326274-B1 | PLASMA KALLIKREIN INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-0048050-A1 | Simultaneous expansion and cure of polyester resin composition | UNIROYAL, INC. (US) | 1982-03-24 | — | — | EP | disclosed |
| US-4202892-A | FUNGICIDES, VIRICIDES, ANTIPROTOZOA AGENTS, PARKINSON'S DISEASE | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1980-05-13 | — | — | US | disclosed |
| EP-0002065-A1 | Methyladamantyl hydrazines, their pharmaceutically acceptable salts and pharmaceutical compositions containing them | Teva Pharmaceutical Industries Limited (IL) | 1979-05-30 | — | — | EP | disclosed |